Donald Trump: Medical device manufacturer BD will invest $3 billion to localize the production of medical products in the United States, with over $1 billion allocated for expansion in Nebraska, attributing this to his tariff policies.
Donald Trump stated that U.S. medical device manufacturer Becton, Dickinson and Company (BD) has agreed to invest $3 billion to localize the production of essential medical products such as syringes, needles, and laboratory kits in the United States. Of this, over $1 billion will be allocated to expansion in Nebraska to increase the output of various products, including needles made from U.S. steel. Trump attributed this to his tough medical device tariff policy, which is set to take effect before the end of this year.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Freda Duan, Partner at Altimeter Capital: AI drug discovery "bottleneck trades" are forming, with triple-digit order growth expected for DNA synthesizers Twist Bioscience and GenScript.
-
2
Cerebras's pre-market stock rose 6% after OpenAI CEO Altman called Cerebras a "close partner."
-
3
Ethereum: Market Impact, Technological Advancements, and Future Outlook
-
4
NVIDIA's $20 billion Groq deal faces lawsuit, accused of undervaluing shareholder worth and evading a vote.
-
5
Multiple U.S. states will vote on wealth taxes in November, with California potentially imposing a 5% net worth tax on billionaires.
-
6
Bitcoin (BTC): Latest Updates and Market Analysis of Digital Gold
-
7
Circle and Tether unite against MiCA bank reserve rules, with Circle proposing looser standards
-
8
KKR Reaches Agreement to Acquire Private Capital Fund Administrator Gen II
-
9
NEXTPredict Conference to Explore Prediction Market Development, Two CFTC Directors to Attend
-
10
French 10-year government bond yields increased, while 10-year Bund yields fell.
Markets Today
Recommended Reading




